UW Health’s Eastpark Medical Center in Madison, Wis., is on track to become one of the first sites in the world to offer upright proton therapy, with treatment expected to begin in summer 2026. The health system completed construction of…
The Latest
Raymond Hohl, MD, PhD, resigned as director of the Penn State Cancer Institute Nov. 21 — one day after Spotlight PA published a report detailing internal reviews that found issues related to the former leader’s care of patients and hostile…
At 9.7%, Gallup polling has found the highest-ever percentage of U.S. adults who report receiving a cancer diagnosis, the analytics firm said Nov. 24. The 2024-2025 figure is a significant increase from the 7% Gallup reported in 2008-2009. The percentage…
City of Hope Orange County (Calif.) has finalized the county’s only cancer specialty hospital, part of its $1.5 billion Orange County expansion. The 73-bed hospital in Irvine, Calif., is set to welcome its first patients Dec. 1, according to a…
Detroit-based Barbara Ann Karmanos Cancer Institute has become the first cancer center in Michigan to administer a newly approved tumor-infiltrating lymphocyte therapy, lifileucel, to a patient with advanced melanoma. The one-time treatment, marketed as Amtagvi, was approved by the FDA…
Washington, D.C.-based Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital has received $40 million in philanthropic funding to establish a new Pediatric Radiation Oncology Research Center. The new center will collaborate with institutions including Boston-based Mass General Brigham for…
Newark, Del.-based ChristianaCare will expand oncology services at the Middletown (Del.) Health Center, which is under construction and expected to open in May 2027. The new location, in which the health system is investing $92.3 million, will provide multidisciplinary cancer…
New York City-based Montefiore Einstein Comprehensive Cancer Center is diagnosing more patients with stage 1 lung cancer than stage 4 for the first time in decades. In 2024, stage 4 lung cancer diagnoses fell to 34% while stage 1 diagnoses…
Expanding screening criteria set by the U.S. Preventive Services Task Force would increase lung cancer detection from 35.1% to 62.1%, according to a study published Nov. 20 in JAMA Network Open. Researchers analyzed data from 997 lung cancer patients diagnosed…